Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
Clinical and Experimental Pharmacology & Physiology|February 28, 2019
Pharmacological inhibition of protease-activated receptor-2 reduces crescent formation in rat nephrotoxic serum nephritisYingjie Han, Lifang Tian, Frank Ma, et al.
Physiological Reports|February 17, 2025
Metabolite pathway alterations identified by magnetic resonance metabolomics in a proximal tubular epithelial cell line treated with TGF-β1Tyrone L R Humphries, Soobin Lee, Aaron J Urquhart, et al.
Biochemical and Biophysical Research Communications|March 21, 2016
Decreased apoptosis repressor with caspase recruitment domain confers resistance to sunitinib in renal cell carcinoma through alternate angiogenesis pathwaysGlenda C Gobe, Keng Lim Ng, David M Small, et al.
Frontiers in Physiology|March 29, 2021
PAR2 Activation on Human Kidney Tubular Epithelial Cells Induces Tissue Factor Synthesis, That Enhances Blood ClottingAbishek Iyer, Tyrone L R Humphries, Evan P Owens, et al.
Archives of Medical Research|April 23, 2014
Protein-bound uremic toxins, inflammation and oxidative stress: a cross-sectional study in stage 3-4 chronic kidney diseaseMegan Rossi, Katrina L Campbell, David W Johnson, et al.
Nephrology (Carlton, Vic.)|July 18, 2019
Protease-activated receptor 2 does not contribute to renal inflammation or fibrosis in the obstructed kidneyFrank Y Ma, Yingjie Han, Elyce Ozols, et al.
ACS Medicinal Chemistry Letters|December 21, 2016
PAR2 Modulators Derived from GB88Mei-Kwan Yau, Ligong Liu, Jacky Y Suen, et al.
Cancers|August 14, 2025
Biomarkers in Renal Cell Carcinoma: A Systematic Review and Immunohistochemical Validation StudyBrett Berezowski, Robert Boothe, Billy Chaplin, et al.
Pageof 10